Clinical Trials Logo

Clinical Trial Summary

Acute Aortic Syndrome (AAS)/Aortic Aneurysm is a common feature of aortic wall events, including aortic dissection, intramural hematoma, aortic ulceration and aortic trauma, and occurs in up to 35 cases per 100,000 cases per year between the ages of 65 and 75 years. Increased levels of the inflammatory biomarker high-sensitivity C-reactive protein predict cardiovascular events. Since statins lower levels of high-sensitivity C-reactive protein as well as cholesterol, the authors hypothesized that people with acute aortic syndrome but without hyperlipidemia might benefit from statin treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04699279
Study type Interventional
Source Nanjing Medical University
Contact Hong Liu, MD
Phone 18801281613
Email DR.HONGLIU@FOXMAIL.COM
Status Recruiting
Phase N/A
Start date January 1, 2021
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT03647566 - 18F Sodium Fluoride PET/CT in Acute Aortic Syndrome
Recruiting NCT05965453 - Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
Recruiting NCT05339529 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Thymosin α1) V N/A
Recruiting NCT06277895 - VOCs in Patients With Acute Cardiogenic Chest Pain N/A
Completed NCT02273245 - Is a Pre-contrast Scan Necesary to Diagnose Acute Aortic Syndrome? N/A
Completed NCT04711889 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Ulinastatin) II N/A
Enrolling by invitation NCT04398992 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
Completed NCT04751058 - Genetic Profile in Patients With Aortic Syndrome
Completed NCT04430400 - Integrated Diagnostic Algorithm for Acute Aortic Syndromes
Completed NCT01259843 - French National Observatory of Aortic Syndromes